AIDS Research and Human Retroviruses was the very first AIDS publication in the field over 30 years ago, and today it is still the critical resource advancing research in retroviruses, including AIDS. The Journal provides the broadest coverage from molecular biology to clinical studies and outcomes research, focusing on developments in prevention science, novel therapeutics, and immune-restorative approaches. Cutting-edge papers on the latest progress and research advances through clinical trials and examination of targeted antiretroviral agents lead to improvements in translational medicine for optimal treatment outcomes.
AIDS Research and Human Retroviruses coverage includes:
HIV cure research
HIV prevention science
- Vaccine research
- Systemic and Topical PreP
Molecular and cell biology of HIV and SIV
Developments in HIV pathogenesis and comorbidities
Molecular biology, immunology, and epidemiology of HTLV
Pharmacology of HIV therapy
Social and behavioral science
Rapid publication of emerging sequence information
AIDS Research and Human Retroviruses is under the editorial leadership of Editor-in-Chief Thomas Hope, PhD, Feinberg School of Medicine, Northwestern University, Deputy Editor Edward M. Campbell, PhD, Stritch School of Medicine, Loyola University Chicago, and other leading investigators. View the entire editorial board.
Audience: HIV/AIDS researchers, virologists, infectious disease specialists, pathologists, molecular biologists, epidemiologists, molecular geneticists, and microbiologists, among others.

AIDS Research and Human Retroviruses provides “Instant Online” publication 72 hours after acceptance.